Research Summary
Dr. Jaar is interested in the conduct of epidemiologic studies in the field of end-stage renal disease and its related complications. His personal research interest is currently focused on outcome studies of peripheral arterial disease (PAD) in end-stage renal disease (ESRD) patients and morbidity and mortality of ESRD patients by dialysis modality. In addition to leading the Cardiovascular Endpoint Committee of the CHOICE study, he is involved in several research projects within the Division of Nephrology and also at the Welch Center for Prevention, Epidemiology and Clinical Research, and the Department of Environmental Health at the School of Public Health.
Clinical Trials
Providing Resources to Enhance Patients' Readiness to Make Decisions About Kidney Disease: The PREPARE NOW Study (PREPARE NOW)
Selected Publications
Abougergi M, Broor A, Cui W, Jaar BG. “Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature.” J Hosp Med. 2010 Jan;5(1):E1-9. doi: 10.1002/jhm.542.
Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, Melamed ML, Powe NR, Jaar BG. “Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis.” Clin J Am Soc Nephrol. 2009 Oct;4(10):1637-1645.
Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, Weaver V. “Blood cadmium and lead and chronic kidney disease in us adults: a joint analysis.” Am J Epidemiol. 2009 Nov 1;170(9):1156-64. doi: 10.1093/aje/kwp248. Epub 2009 Aug 21.
Sozio SM, MD, Armstrong PA, Coresh J, Jaar BG, Fink NE, Plantinga LC, Powe NR, Parekh RS. “Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.” Am J Kidney Dis. 2009 Sep;54(3):468-77. doi: 10.1053/j.ajkd.2009.01.261. Epub 2009 Apr 19.
Sperati CJ, Parekh RS, Berthier-Schaad Y, Jaar BG, Plantinga L, Fink N, Powe N, Smith MW, Coresh J, Kao WHL. “Association of single nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients.” Am J Kidney Dis. 2009 May;53(5):845-55. doi: 10.1053/j.ajkd.2008.12.025. Epub 2009 Mar 12.
Charles RF, Powe NR, Jaar BG, Troll MU, Parekh RS, Boulware LE. “Clinical testing patterns and cost implications of variation in the evaluation of chronic kidney disease among U.S. physicians.” Am J Kidney Dis. 2009 Aug; 54(2): 227–237.
Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. “Association of peritoneal dialysis clinic size with clinical outcomes.” Perit Dial Int. 2009 May-Jun;29(3):285-91.
Weaver VM, Griswold M, Todd AC, Jaar BG, Ahn KD, Thompson CB, Lee BK. “Longitudinal associations between lead dose and renal function in lead workers.” Environ Res. 2009 Jan;109(1):101-7. doi: 10.1016/j.envres.2008.09.005. Epub 2008 Nov 26.
Crews D, Jaar BG. “Racial differences in chronic kidney disease incidence and progression among individuals with HIV.” Nat Clin Pract Nephrol. 2008 Dec; 4(12): 652–653.
Parekh RS, Meoni LA, Kao WHL, Plantinga LC, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ. “The association of sudden cardiac death with inflammation and other traditional risk factors.” Kidney International. 2008;74(10):1335-1342.
